Found 6 matching trials
Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma PHASE3 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Fred Hutchinson Cancer Research Center
Learn More & Join Trial
Study Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan Alone, With Stem Cell Transplant in Multiple Myeloma PHASE3 STR (Skeletal Targeted Radiotherapy, 166Ho-DOTMP) is an investigational rad...
Show More Location
University of Alabama
Learn More & Join Trial
Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Ewing's Sarcoma or Rhabdomyosarcoma That Has Spread to the Bone PHASE1 RATIONALE: Radioactive drugs, such as holmium Ho 166 DOTMP, may carry radia...
Show More Location
Fred Hutchinson Cancer Research Center
Learn More & Join Trial
A Trial of Skeletal Targeted Radiotherapy Using Holmium-166-DOTMP in Patients With Multiple Myeloma PHASE1 Multiple myeloma is a disease that resides primarily in the bone and has sh...
Show More Location
Multiple Locations
Learn More & Join Trial
Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma PHASE1 RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Show More Location
University of Alabama at Birmingham Comprehensive Cancer Center
Learn More & Join Trial
Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma PHASE1 RATIONALE: Radiation therapy using holmium Ho 166 DOTMP may damage cancer c...
Show More Location
Sylvester Cancer Center, University of Miami
Learn More & Join Trial